+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Implantable Drug Delivery Devices Global Market Report 2022

  • PDF Icon

    Report

  • 200 Pages
  • May 2022
  • Region: Global
  • The Business Research Company
  • ID: 5597279
Implantable Drug Delivery Devices Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global implantable drug delivery devices market.

This report focuses on implantable drug delivery devices market which is experiencing strong growth. The report gives a guide to the implantable drug delivery devices market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates
  • Create regional and country strategies on the basis of local data and analysis
  • Identify growth segments for investment
  • Outperform competitors using forecast data and the drivers and trends shaping the market
  • Understand customers based on the latest market research findings
  • Benchmark performance against key competitors
  • Utilize the relationships between key data sets for superior strategizing
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:

Where is the largest and fastest growing market for the implantable drug delivery devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Implantable Drug Delivery Devices market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider implantable drug delivery devices market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth
  • Market segmentations break down market into sub markets
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers
  • The implantable drug delivery devices market section of the report gives context. It compares the implantable drug delivery devices market with other segments of the implantable drug delivery devices market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, implantable drug delivery devices indicators comparison

Scope


Markets Covered:

1) By Product: Contraceptive Implants; Spinal Implants; Brachytherapy Seeds; Drug-Eluting Stents; Bio-absorbable Stents; Intraocular Stents; Infusion Pumps; Other Applications
2) By Technology: Diffusion; Osmotic; Magnetic; Other Technologies
3) By Application: Contraception; Ophthalmology; Cardiovascular; Diabetes; Oncology; Autoimmune Diseases; Other Applications

Companies Mentioned: Allergan inc.; Bayer HealthCare; Medtronic Inc.; Nucletron; Boston Scientific Corporation

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary2. Implantable Drug Delivery Devices Market Characteristics3. Implantable Drug Delivery Devices Market Trends And Strategies4. Impact Of COVID-19 On Implantable Drug Delivery Devices
5. Implantable Drug Delivery Devices Market Size And Growth
5.1. Global Implantable Drug Delivery Devices Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Implantable Drug Delivery Devices Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Implantable Drug Delivery Devices Market Segmentation
6.1. Global Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Contraceptive Implants
  • Spinal Implants
  • Brachytherapy Seeds
  • Drug-Eluting Stents
  • Bio-absorbable Stents
  • Intraocular Stents
  • Infusion Pumps
  • Other Products
6.2. Global Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Diffusion
  • Osmotic
  • Magnetic
  • Other Technologies
6.3. Global Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Contraception
  • Ophthalmology
  • Cardiovascular
  • Diabetes
  • Oncology
  • Autoimmune Diseases
  • Other Applications

7. Implantable Drug Delivery Devices Market Regional And Country Analysis
7.1. Global Implantable Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Implantable Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8. Asia-Pacific Implantable Drug Delivery Devices Market
8.1. Asia-Pacific Implantable Drug Delivery Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8.3. Asia-Pacific Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
9. China Implantable Drug Delivery Devices Market
9.1. China Implantable Drug Delivery Devices Market Overview
9.2. China Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
9.3. China Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
10. India Implantable Drug Delivery Devices Market
10.1. India Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
10.2. India Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11. Japan Implantable Drug Delivery Devices Market
11.1. Japan Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11.2. Japan Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12. Australia Implantable Drug Delivery Devices Market
12.1. Australia Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12.2. Australia Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13. Indonesia Implantable Drug Delivery Devices Market
13.1. Indonesia Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13.2. Indonesia Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14. South Korea Implantable Drug Delivery Devices Market
14.1. South Korea Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14.2. South Korea Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15. Western Europe Implantable Drug Delivery Devices Market
15.1. Western Europe Implantable Drug Delivery Devices Market Overview
15.2. Western Europe Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15.3. Western Europe Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16. UK Implantable Drug Delivery Devices Market
16.1. UK Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16.2. UK Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17. Germany Implantable Drug Delivery Devices Market
17.1. Germany Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17.2. Germany Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18. France Implantable Drug Delivery Devices Market
18.4. France Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18.5. France Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19. Eastern Europe Implantable Drug Delivery Devices Market
19.1. Eastern Europe Implantable Drug Delivery Devices Market Overview
19.2. Eastern Europe Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19.3. Eastern Europe Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20. Russia Implantable Drug Delivery Devices Market
20.1. Russia Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20.2. Russia Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21. North America Implantable Drug Delivery Devices Market
21.1. North America Implantable Drug Delivery Devices Market Overview
21.2. North America Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21.3. North America Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22. USA Implantable Drug Delivery Devices Market
22.1. USA Implantable Drug Delivery Devices Market Overview
22.2. USA Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22.3. USA Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23. South America Implantable Drug Delivery Devices Market
23.1. South America Implantable Drug Delivery Devices Market Overview
23.2. South America Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23.3. South America Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24. Brazil Implantable Drug Delivery Devices Market
24.1. Brazil Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24.2. Brazil Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25. Middle East Implantable Drug Delivery Devices Market
25.1. Middle East Implantable Drug Delivery Devices Market Overview
25.2. Middle East Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25.3. Middle East Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26. Africa Implantable Drug Delivery Devices Market
26.1. Africa Implantable Drug Delivery Devices Market Overview
26.2. Africa Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26.3. Africa Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
27. Implantable Drug Delivery Devices Market Competitive Landscape And Company Profiles
27.1. Implantable Drug Delivery Devices Market Competitive Landscape
27.2. Implantable Drug Delivery Devices Market Company Profiles
27.2.1. Allergan Inc
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Bayer HealthCare
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Medtronic Inc.
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Nucletron
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Boston Scientific Corporation
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers And Acquisitions In The Implantable Drug Delivery Devices Market29. Implantable Drug Delivery Devices Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright And Disclaimer

Executive Summary

Major players in the implantable drug delivery devices market are Allergan Inc, Bayer HealthCare, Medtronic Inc, Nucletron, Boston Scientific Corporation, Abbott Laboratories, Bausch and Lomb Inc, Merck, Genetech Inc, and Psivida.

The global implantable drug delivery devices market is expected to grow from $17.20 billion in 2021 to $18.35 billion in 2022 at a compound annual growth rate (CAGR) of 6.7%. The market is expected to grow to $24.08 billion in 2026 at a compound annual growth rate (CAGR) of 7.0%.

The implantable drug delivery devices market consists of sales of implantable drug delivery devices and related services by companies that manufacture them. Implantable drug delivery devices are drug delivery systems implanted by surgery to allow site-specific drug administration at the tissue or organ where the drug is most needed.

The main product of implantable drug delivery devices is contraceptive implants, spinal implants, brachytherapy seeds, drug-eluting stents, bioabsorbable stents, intraocular stents, infusion pumps, and others. Spinal implants are devices that are used by surgeons while performing surgery to treat deformity, stabilize and strengthen the spine, and facilitate fusion. The technologies involved are diffusion, osmotic, magnetic, and others. The various applications involved are contraception, ophthalmology, cardiovascular, diabetes, oncology, autoimmune diseases, and others.

North America was the largest region in the implantable drug delivery devices market in 2021. Asia Pacific was the second-largest region in the implantable drug delivery devices market. The regions covered in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The rise in the incidence of target diseases such as diabetic retinopathy, cancer, cardiovascular diseases, and other chronic diseases is expected to drive the implantable drug delivery devices market. According to the International Diabetes Federation (IDF), the global prevalence of diabetic retinopathy was around 27% in 2019. Implantable drug delivery devices are used for site-specific drug administration where the drug is most needed, such as Gliadel® wafer as an implant used in the treatment of brain tumors, Lupron depot for the treatment of prostate cancer. Hence, the site-specific drug administration nature of implantable drug devices, which help in the treatment of target diseases, is driving the implantable drug delivery devices market.

The rising number of product recalls and lawsuits associated with implantable drug delivery devices is expected to hinder the market. In the past few years, there had been an increase in product recalls and lawsuits connected with these devices. For instance, in December 2019, around 7,000 Medtronic SynchroMed II, implantable drug infusion pumps were recalled due to the presence of foreign bodies in them. Nexplanon, a small rod contraceptive implant inserted into the skin of the upper arm to prevent pregnancy for up to three years, is facing a lawsuit, and lawyers and attorneys at National Injury Help have been investigating all such cases against those injured by Nexplanon. Therefore, the rising number of product recalls and lawsuits concerning implantable drug delivery devices is expected to hinder the growth of the market.

Companies and researchers are focusing on developing 3D implantable drug delivery devices. 3D printed titanium transcutaneous ports are implanted behind the patient's ear, allowing healthcare professionals to access the catheters. For instance, in February 2020, Renishaw and Herantis Pharma announced the award-winning device, which received positive results in phase 2 trials, that consists of up to four catheters implanted in the relevant brain areas. Researchers at King Abdullah University of Science and Technology have introduced a miniaturized drug delivery system suitable for in-vivo biomedical applications. The system consists of an electrolytic pump, which operates a micro bellows membrane as an actuator for delivery through microneedles. A two-photon 3D printing technique was used to make a reservoir equipped with a microneedle.

In November 2019, Dare Bioscience, a USA-based biopharmaceutical company with a special focus on women's health, has acquired Microchips Biotech for an amount of $102 million. Through this acquisition, Microchips has become the wholly subsidiary of Dare Bioscience. Microchips Biotech is a USA-based company developing innovative drug implants.

The countries covered in the implantable drug delivery devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Allergan inc.
  • Bayer HealthCare
  • Medtronic Inc.
  • Nucletron
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Bausch and Lomb inc.
  • Merck
  • Genetech Inc.
  • Psivida
  • Nucletron

Methodology

Loading
LOADING...